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Ireland, and Bratislava, SlovakiaBackground: Preterm birth, low birth weight, and infant catch-up
growth seem associated with an increased risk of respiratory
diseases in later life, but individual studies showedconflictingresults.
Objectives: We performed an individual participant data
meta-analysis for 147,252 children of 31 birth cohort studies
to determine the associations of birth and infant growth
characteristics with the risks of preschool wheezing (1-4 years)
and school-age asthma (5-10 years).
Methods: First, we performed an adjusted 1-stage random-
effect meta-analysis to assess the combined associations of
gestational age, birth weight, and infant weight gain with
childhood asthma. Second, we performed an adjusted 2-stage
random-effect meta-analysis to assess the associations of
preterm birth (gestational age <37 weeks) and low birth weight
(<2500 g) with childhood asthma outcomes.
Results: Younger gestational age at birth and higher infantweight
gain were independently associated with higher risks of preschool
wheezing and school-age asthma (P<.05). The inverse associations
of birth weight with childhood asthma were explained by
gestational age at birth. Compared with term-born children with
normal infant weight gain, we observed the highest risks of
school-age asthma in children born preterm with high infant
weight gain (odds ratio [OR], 4.47; 95% CI, 2.58-7.76). Preterm
birth was positively associated with an increased risk of preschool
wheezing (pooled odds ratio [pOR], 1.34; 95% CI, 1.25-1.43) and
school-age asthma (pOR, 1.40; 95%CI, 1.18-1.67) independent of
birth weight. Weaker effect estimates were observed for the
associations of low birth weight adjusted for gestational age at
birth with preschool wheezing (pOR, 1.10; 95% CI, 1.00-1.21)
and school-age asthma (pOR, 1.13; 95% CI, 1.01-1.27).Conclusion: Younger gestational age at birth and higher infant
weight gain were associated with childhood asthma outcomes.
The associations of lower birth weight with childhood asthma
were largely explained by gestational age at birth. (J Allergy
Clin Immunol 2014;133:1317-29.)
Key words: Gestational age, low birth weight, infant growth,
wheezing, asthma, children, cohort studies, epidemiology
Respiratory diseases have at least part of their origins in early
life. It has been hypothesized that adverse exposures in fetal and
early postnatal life might influence lung growth and development,
which could lead to persistently smaller airways and impaired
lung function. These developmental adaptationsmight predispose
the subject to asthma and chronic obstructive pulmonary disease
in childhood and adulthood.1-3 This hypothesis is supported by
studies showing associations of low birthweightwith an increased
risk of wheezing and asthma in childhood4-7 and chronic obstruc-
tive pulmonary disease and lower pulmonary function in later
life.8-11 Published findings are not consistent,4-7,12,13 which might
be due to differences in study populations and in definitions of
outcomes. Also, the observed associations of low birth weight
with an increased risk of asthma-related outcomes might be
confounded by preterm birth or catch-up growth in infancy. The
lungs of preterm children havenot yet been fully developed,which
makes them prone to suboptimal further development.14-16
Most children with low birth weight show catch-up growth in
infancy.17 Recent studies suggested that catch-up growth is asso-
ciated with lower pulmonary function and an increased risk of1317
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of gestational age, birth weight, and infant growth.METHODS
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SONNENSCHEIN-VAN DER VOORT ET AL 1319www.ga2len.org, and www.birthcohorts.net assessed until May 29, 2012). We
invited the 52 potentially eligible cohorts, of which 41 responded to our
invitation. From those, 31 cohorts agreed to participate, leading to 147,252
children with information on at least 1 early growth characteristic and
respiratory outcome (see the flow chart shown in Fig E1 in this article’s Online
Repository at www.jacionline.org). All original cohort studies were approved
by their local institutional review boards and provided written informed
consent for using their data. Anonymized data sets were stored on a single
central secured data server with access for the main analysts (A.M.M.S.,
L.R.A., and L.D.) only.
Birth characteristics and infant growth
Information about birth weight, gestational age at birth, and weight in the
first year of life per cohort was obtained by using measurements, medical
registries, or parental questionnaires (cohort-specific information is shown in
Table E1 in this article’s Online Repository at www.jacionline.org) and used as
continuous and categorical variables. Infant weight gain in the first year was
defined as the difference between weight at 1 year (range, 6-18 months) and
weight at birth divided by the exact number of months between those 2
measurements. We created gestational age–adjusted birth weight standard
deviation scores (SDS) based on a North-European reference chart.21 No
general European or World Health Organization reference curves of birth
weight for gestational age are available. To test nonlinear and dose-response
associations, we categorized gestational age (<28.0, 28.0-29.9, 30.0-31.9,
32.0-33.9, 34.0-35.9, 36.0-37.9, 38.0-39.9, 40-41.9, and >_42 weeks),
birth weight SDS (<24, 24 to 23.01, 23 to 22.01, 22 to 21.01, 21 to
20.01, 0 to 0.99, 1 to 1.99, 2 to 2.99, 3 to 3.99, and >_4 SDS), and infant weight
gain (<300, 300-399, 400-499, 500-599, 600-699, 700-799, 800-899, 900-999,
and >_1000 g/mo). To test the combined associations of gestational age, birth
weight SDS, and infant weight gain with childhood asthma outcomes, we
used a smaller number of groups to have sufficient children per group
(for gestational age: <32, 32-35.9, 36-39.9, and >_40 weeks; for birth weight
SDS: <22; 22 to 21.01, 21 to 0.99, 1 to 1.99, and >_2 SDs; and for
infant weight gain: <500, 500-599, 600-699, and >_700 g/mo). Finally, we
dichotomized gestational age at birth into term birth (>_37 weeks) and preterm
birth (gestational age, <37 weeks) and birth weight into normal birth weight
(>_2500 g) and low birth weight (<2500 g) to test the effects of clinical birth
complications on childhood asthma outcomes. Cohort-specific characteristics
of determinants are shown in Table E2 in this article’s Online Repository at
www.jacionline.org.
Asthma-related outcomes in childhood
We used preschool wheezing and school-age asthma as the main outcomes.
These data were mainly obtained by using questionnaires adapted from the
International Study on Asthma and Allergy in Childhood (ISAAC).22 Cohort-
specific information is shown in Table E1. We defined preschool wheezing as
‘‘ever reported wheezing during the first 4 years of life (no, yes)’’ and
school-age asthma as ‘‘asthma diagnosis reported between 5 and 10 years
(no, yes),’’ preferably physician diagnosed. If cohorts had repeatedly collected
data on ever wheezing in the first 4 years or asthma diagnosis between 5 and 10
years of life, we used data collected at the oldest age.
Covariates
We included covariates based on known associations with childhood
asthma from previous studies.23-27 Information on covariates was mostly as-
sessed by using questionnaires (see Table E1). The individual cohort analyses
were adjusted for potential confounders, including maternal educational level
(low, medium, high), smoking during pregnancy (no, yes), history of asthma
(no, yes), smoking during infancy of their offspring (no, yes), child’s sex
(female, male), siblings (no, yes), and attending day care in the first 2 years
of lice (no, yes; description of available covariates per cohort is shown in
Table E3 in this article’s Online Repository at www.jacionline.org). We
considered breast-feeding status (never, ever), lower respiratory tract
infections (no, yes), and eczema (no, yes) in the first 2 years of life as potential
intermediates (description of available intermediates per cohort is shown in
Table E4 in this article’s Online Repository at www.jacionline.org).Statistical analysis
First, we performed a 1-stage random-effect meta-analysis on an individual
participant’s data to examine the separate and combined associations of
gestational age, birth weight, and infant weight gain with preschool wheezing
and school-age asthma. For this analysis, individual participants’ data from all
cohorts were included in 1 multilevel analysis and were analyzed, simulta-
neously taking into account clustering of participants within studies.28
Because we used a Northern European reference curve for birth weight for
gestational age (birth weight SDS), we performed a sensitivity analysis to
explore whether the association was different in Northwest European subjects
only (Denmark, France, Germany, Ireland, The Netherlands, Norway, Swe-
den, Switzerland, and United Kingdom).29 Numbers were too low to perform
these analyses separately in other European regions.
Second, we performed a 2-stage random-effect meta-analysis to examine the
associations of gestational age at birth, birth weight, and infant weight gain and
dichotomized preterm birth and low birth weight with the risks of preschool
wheezing and school-age asthma. For this analysis, which was used for the
clinically relevant associations of preterm birth and low birth weight, we first
used logistic regressionmodels to calculate effect estimates per cohort and then
used calculated pooled odds ratios (pORs) from the per-cohort effect
estimates.28 To enable comparison of effect estimates, results for birth weight
and infant weight gain are presented as pORs per 500 g/mo and 100 g/mo
increase, respectively, which reflect the corresponding SDs. We tested for het-
erogeneity by calculating the Cochran Q and I2 values, which varied per anal-
ysis.30 We used random-effects models, which take into account the potential
between-study variation next to the within-study variation.31 To determine the
influence of any particular cohort on overall results, we repeated each meta-
analysis, leaving out 1 cohort at the time. The first model was adjusted for the
child’s sex (crudemodel), the secondmodelwas additionally adjusted for poten-
tial confounders (confounder model), and the third model was additionally
adjusted for potential intermediates (intermediate model). We considered the
confounder model as the main model. Results are presented as forest plots or
tables with central point estimates from the random-effect models with their
95% CIs. The number of cohorts and children per meta-analysis differed
because of differences in data availability. For all analyses, missing values in
covariates were used as an additional group in the categorical variables to pre-
vent exclusion of noncomplete cases.We also performed a complete-case sensi-
tivity analysis to explore any differences with complete-case analyses and
sensitivity analyses in which we first excluded children with parent-reported
birth weight and then excluded children without ISAAC-based questionnaires
on wheezing. Statistical analyses were performed with SAS 9.2 software
(SAS Institute, Cary, NC) and Comprehensive Meta-Analysis (Biostat).RESULTS
Subjects’ characteristics
The cohort-specific information about the main exposures and
outcomes are shown in Table I. The overall prevalences of pre-
term birth (gestational age <37 weeks) and low birth weight
(<2500 g) were 5.1% and 3.9%, respectively. Overall preschool
wheezing prevalence was 31.6%, and overall school-age asthma
prevalence was 12.8%.Gestational age, birth weight, and infant weight
gain
In the 1-stage meta-analysis of individual participants’ data, we
observed consistent inverse associations of gestational age at birth
with the risk of preschool wheezing and school-age asthma.
Comparedwith term-born children, children born before 28weeks
of gestation had the highest risk of preschool wheezing (odds ratio
[OR], 3.87; 95% CI, 2.70-5.53) and school-age asthma (OR, 2.92;
95%CI, 1.84-4.62; Fig 1,A andB). Almost all children born before
a gestational age of 40.0 weeks had an increased risk of preschool
wheezing and school-age asthma. Birth weight SDS were not
TABLE I. Characteristics of the participating European birth cohorts
Cohort name (country) No. (total 5 147,252) Birth years Birth weight (g), mean (SD)
Gestational age at birth (wk),
median (5% to 95% range)
ABIS (Sweden) 6,829 1997-1998 3,576 (537) 40 (37-42)
ALSPAC (United Kingdom) 12,485 1991-1992 3,403 (554) 40 (36-42)
BILD (Switzerland) 432 1999 3,382 (441) 39 (37-41)
CONER (Italy) 389 2004-2005 3,321 (448) 39 (37-41)
COPSAC (Denmark) 384 1998-2001 3,513 (524) 40 (37-42)
CZECH (Czech Republic) 1,830 2001-2004 3,331 (519) 40 (36-41)
DNBC (Denmark) 76,810 1996-2001 3,594 (555) 40 (37-42)
EDEN (France) 1,774 2003-2005 3,285 (506) 40 (36-41)
GASPII (Italy) 694 2003-2004 3,313 (529) 40 (36-41)
GECKO Drenthe (The Netherlands) 1,718 2006-2007 3,557 (544) 40 (37-42)
GENERATION R (The Netherlands) 5,815 2002-2006 3,428 (575) 40 (37-42)
GENERATION XXI (Portugal) 7,053 2005-2006 3,149 (533) 39 (35-41)
HUMIS (Norway) 2,001 2003-2008 3,534 (677) 40 (34-42)
INMA Gipuzkoa (Spain) 478 2006-2008 3,298 (446) 40 (37-42)
INMA Menorca (Spain) 474 1997-1998 3,186 (498) 40 (37-41)
INMA Sabadell (Spain) 502 2004-2007 3,253 (412) 40 (37-42)
INMAValencia (Spain) 604 2003-2005 3,247 (501) 40 (37-42)
ISLE OF WIGHT (United Kingdom) 1,405 1989-1990 3,411 (523) 40 (38-42)
KOALA (The Netherlands) 2,151 2000-2003 3,525 (499) 40 (38-42)
LEICESTER 1990 (United Kingdom) 1,231 1990 3,381 (555) 40 (36-41)
LEICESTER 1998 (United Kingdom) 6,836 1998 3,289 (582) 39 (36-41)
LIFEWAYS (Ireland) 421 2001-2002 3,526 (565) 40 (38-42)
MAS (Germany) 1,263 1990 3,412 (463) 40 (37-42)
NINFEA (Italy) 1,922 2005-2010 3,215 (508) 40 (36-42)
PCB (Slovakia) 429 2001-2004 3,359 (492) 40 (38-41)
PIAMA (The Netherlands) 3,631 1996-1997 3,515 (543) 40 (37-42)
REPRO PL (Poland) 314 2007-2011 3,349 (480) 40 (37-41)
RHEA (Greece) 1,046 2007-2008 3,179 (437) 38 (36-40)
SEATON (United Kingdom) 1,891 1997 3,414 (610) 40 (35-42)
SWS (United Kingdom) 2,291 1998-2007 3,442 (555) 40 (37-42)
WHISTLER (The Netherlands) 2,149 2001-2012 3,525 (513) 40 (37-42)
No., Number of participants with information on at least birth weight or gestational and a respiratory outcome.
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and D). Results for birth weight in grams without taking gesta-
tional age into account are shown in Fig E2 in this article’s Online
Repository atwww.jacionline.org, showing an inverse association.
We observed a positive association of infant weight gain with pre-
school wheezing and school-age asthma. Compared with children
with a weight gain of between 500 and 600 g/mo (largest group),
children with a mean infant weight gain of between 900 and 1000
g/mo had the highest risk of preschool wheezing (OR, 1.79; 95%
CI, 1.45-2.21) and school-age asthma (OR, 1.69; 95% CI,
1.19-2.38; Fig 1, E and F). The overall results for the linear asso-
ciations of gestational age at birth, birth weight, and infant weight
gain from the 1-stagemeta-analysis of individual participants’data
were similar to those from the 2-stage meta-analysis of individual
participants’ data (results are shown in Table E5 in this article’s
Online Repository at www.jacionline.org). The results from the
confounder model were not materially different from those from
the crude model. Also, additionally adjusting the confounder
model for potential intermediates (breast-feeding, lower respira-
tory tract infections, and eczema) did not materially change the
effect estimates (results are shown in Tables E6 and E7 in this
article’s Online Repository at www.jacionline.org). Also, we
observed similar effect estimates for preschool wheezing and
school-age asthma after excluding cohorts one by one, indicatingno disturbing effect of any particular population (data not shown).
After exclusion of the Danish National Birth Cohort, the largest
cohort in our meta-analysis (COPSAC) and a high-risk asthma
and atopy cohort, we also did not observe major changes in effect
estimates (data not shown).
Next, we explored the combined effects of gestational age at
birth, birth weight SDS, and infant weight gain. The significant
correlations were between gestational age and birth weight (r 5
0.58, P < .001), between gestational age and infant weight gain
(r520.16, P <.001), and between birth weight and infant weight
gain (r520.12,P<.001).We performed stratified analyses and an
overall test for interaction. In each analysis the largest group was
used as the reference group. For the combined effect analysis of
gestational age at birth and birth weight SDS, we observed a higher
risk of preschool wheezing among children born at an earlier age
with higher birth weight SDS, but the overall interaction term
with birth weight SDS was not significant (Fig 2, A). Similarly,
we observed a tendency toward a higher risk of school-age asthma
in children born at an earlier gestational age with higher birth
weight SDS (P for interaction 5 .04; Fig 2, B). The highest risks
for school-age asthma were observed for children born before 32
weeks of gestation with a moderately high birth weight SDS
(OR, 3.47; 95% CI, 1.65-7.31) and with a high birth weight SDS
(OR, 2.63; 95% CI, 0.53-13.13) compared with children born at
Preschool wheezing, % (no.) School-age asthma, % (no.)
Available covariates
Maternal
education
Prenatal
smoke
Maternal
asthma
Postnatal
smoke Sex Siblings Day care
32.6 (2,200) 9.9 (258) O O O O O O
45.8 (5,683) 21.7 (1,622) O O O O O O O
20.6 (89) — O O O O O
41.4 (161) — O O O O O O
89.5 (331) 18.2 (62) O O O O O O O
— 13.3 (244) O O O O O O
26.9 (17,671) 12.4 (6,498) O O O O O O O
32.3 (573) 12.8 (227) O O O O O O O
43.7 (303) — O O O O O O O
29.2 (501) — O O O O O O
29.3 (1,505) 6.0 (263) O O O O O O O
53.0 (2,970) 4.4 (305) O O O O O
15.0 (301) — O O O O O O O
35.8 (171) — O O O O O O O
47.9 (227) 6.4 (27) O O O O O O O
59.8 (300) — O O O O O O O
25.7 (155) — O O O O O O O
24.2 (263) 20.1 (272) O O O O
24.7 (494) 7.6 (134) O O O O O O
15.0 (156) 30.6 (136) O O O
38.0 (2,242) 22.3 (1,029) O O O O O
— 26.4 (111) O O O O O
18.8 (237) 6.6 (44) O O O O O O O
23.9 (460) — O O O O O O O
5.6 (24) — O O O O
27.3 (964) 10.1 (327) O O O O O O O
12.4 (39) — O O O O O O
25.7 (269) — O O O O O O O
27.3 (517) 14.7 (131) O O O O O O O
70.9 (1,614) 15.4 (145) O O O O O O
27.2 (577) 7.7 (43) O O O O O O
TABLE I. (Continued)
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 5
SONNENSCHEIN-VAN DER VOORT ET AL 1321term with a normal birth weight SDS. The P value for interaction
between gestational age at birth and infant weight gain for the as-
sociations with preschool wheezing and school-age asthma were
0.05 and 0.23, respectively (Fig 2,C andD).We observed the high-
est risk of preschool wheezing and school-age asthma among chil-
dren born before 32 weeks of gestation with an infant weight gain
of more than 700 g compared with children born at term with a
normal weight gain (ORs of 3.27 [95% CI, 2.06-5.19] and 4.47
[95% CI, 2.58-7.76], respectively). The interactions between birth
weight SDSs and infant weight gain for the associations with pre-
school wheezing and school-age wheezing were not significant
(Fig 2, E and F). As a sensitivity analysis, we performed our anal-
ysis in Northwest European cohorts only and observed similar re-
sults (results are shown in Tables E8 and E9 in this article’s Online
Repository at www.jacionline.org). The results of complete case
analyses were similar (data not shown). Also, we observed similar
effect estimates for preschool wheezing and school-age asthma af-
ter excluding cohorts that used parental reports of birth weight or
non–ISAAC-based questions on wheezing. With this exclusion,
only the youngest and lowest weight-for-gestational-age groups
tended to show stronger effects (see Tables E10 and E11 in this ar-
ticle’s Online Repository at www.jacionline.org). This indicates
that differences in data collection did not lead to systematic differ-
ences in effect estimates.Preterm birth, low birth weight, and childhood
asthma outcomes
Results from the 2-stage meta-analysis focused on the associ-
ations of preterm birth and low birth weight with childhood
asthma outcomes are shown in Fig 3. Compared with term-born
children, preterm-born children had an increased risk of preschool
wheezing (pOR, 1.34; 95% CI, 1.25-1.43) and school-age asthma
(pOR, 1.40; 95% CI, 1.18-1.67; Fig 3, A and B). These associa-
tions were independent of birth weight. The population-
attributable risk of preterm birth was 1.96% for preschool
wheezing and 2.14% for school-age asthma. Compared with chil-
dren with a normal birth weight, those with a low birth weight
(<2500 g) had an increased risk of preschool wheezing (pOR,
1.10; 95% CI, 1.00-1.21) and school-age asthma (pOR, 1.13;
95% CI, 1.01-1.27; Fig 3, C and D). These associations were
stronger without adjustment for gestational age at birth (results
are shown in Table E6).DISCUSSION
Results from this large-scale meta-analysis of individual
participants’ data suggested that younger gestational age at birth
and higher infant weight gain were associatedwith increased risks
of preschool wheezing and school-age asthma. The associations
DA
C
E F
B
FIG 1. Associations of gestational age at birth, birth weight, and infant weight gain with preschool wheezing
and school-age asthma. Values are ORs (95% CIs) frommultilevel models for the associations of gestational
age at birth (A and B), gestational age–adjusted birth weight (C and D), and gestational age–and birth
weight–adjusted infant weight gain (E and F) with asthma outcomes. Models are adjusted for confounders
(see the Methods section). Reference groups are represented by open circles.
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explained by gestational age at birth. The highest risk for
childhood asthma outcomes was observed among children born
before a gestational age of 32 weeks with high infant weight gain.Comparison with earlier studies
Adverse exposures in fetal and early postnatal life can lead to
developmental lung adaptations, such as persistently smaller
airways and impaired lung function. These developmental
adaptations might predispose the patients to obstructive pulmo-
nary diseases in childhood and adulthood.1-3 This hypothesis is
supported by studies showing associations of low birth weight
with an increased risk of wheezing and asthma in childhood.4-11Because low birth weight is correlated with gestational age at
birth and infant weight gain, we aimed to disentangle the associ-
ations of both gestational age at birth, gestational age–adjusted
birth weight, and infant weight gain with childhood asthma
outcomes.
Jaakkola et al16 performed a meta-analysis on the associations
of preterm birth with asthma based on 19 published cohort, case-
control, and cross-sectional studies. They observed that preterm-
born children, which were defined as those born before 37 weeks
of gestation, had an increased risk of asthma between 1 and 24
years of age, with a similar effect estimate as observed in our
group of 5- to 10-year-olds. They did not assess associations of
birth weight with asthma outcomes. Also, Flaherman and Ruther-
ford32 performed a meta-analysis on 12 previously published
FIG 2. Combined associations of gestational age at birth, birth weight, and infant weight gain with
preschool wheezing and school-age asthma. Values are ORs (95% CIs) from multilevel models for the
associations of gestational age at birth and birth weight SDSs (A and B), gestational age at birth and infant
weight gain (C and D), and birth weight SDSs and infant weight gain (E and F) with asthma outcomes.
Models are adjusted for confounders (see the Methods section). Reference groups are represented by a
white bar. P values for gestational age*SD birth weight interactions are as follows: wheezing, .97; asthma,
.04. P values for gestational age*weight gain interaction are as follows: wheezing, .05; asthma, .23. P values
for birth weight SDS*weight gain interactions are as follows: wheezing, .15; asthma, .57. *P < .05, **P < .01,
and ***P < .001.
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Study name Statistics for each study
ABIS 1.19 (0.91, 1.57)
ALSPAC 1.59 (1.33, 1.89)
BILD 1.46 (0.26, 1.89)
CONER 0.93 (0.33, 2.62)
COPSAC 2.91 (0.30, 28.35)
DNBC 1.33 (1.22, 1.46)
EDEN 1.82 (1.10, 3.02)
GASPII 1.51 (0.71, 3.23)
GECKO 1.43 (0.83, 2.47)
GENERATION R 1.09 (0.81, 1.47)
GENERATION XXI 1.14 (0.92, 1.42)
HUMIS 1.99 (1.18, 3.35)
INMA GIPUZKOA 3.12 (0.97, 10.05)
INMA MENORCA 3.30 (1.22, 8.92)
INMA SABADELL 1.83 (0.52, 6.47)
INMA VALENCIA 0.98 (0.27, 2.62)
ISLE OF WIGHT 1.62 (0.70, 3.74)
KOALA 1.17 (0.61, 2.23)
LEICESTER 1990 2.79 (0.84, 9.25)
LEICESTER 1998 1.23 (0.96, 1.57)
MAS 2.85 (1.30, 6.27)
NINFEA 1.28 (0.82, 2.01)
PIAMA 1.37 (0.95, 1.98)
REPRO PL 0.92 (0.10, 8.78)
RHEA 0.93 (0.58, 1.51)
SEATON 1.06 (0.62, 1.76)
SWS 1.44 (0.87, 2.39)
WHISTLER 1.20 (0.69, 2.10)
1.34 (1.25, 1.43)
0.1 0.2 0.5 1 2 5 10
Odds ratio (95% CI) Relative weight %
5.72
13.09
0.15
0.42
0.09
37.61
1.76
0.78
1.52
4.86
8.69
1.66
0.33
0.46
0.28
0.47
0.65
1.08
0.31
6.92
0.72
2.22
3.26
0.09
1.97
1.72
1.74
1.44
POOLED
Q = 28, p = 0.424, I² = 3%
ABIS 2.07 (1.14, 3.74)
ALSPAC 1.11 (0.84, 1.45)
COPSAC 5.89 (1.25, 27.83)
CZECH 1.13 (0.60, 2.12)
DNBC 1.45 (1.28, 1.65)
EDEN 1.12 (0.56, 2.24)
GENERATION R 1.97 (1.20, 3.24)
GENERATION XXI 1.46 (0.94, 2.27)
INMA MENORCA 14.54 (3.13, 67.49)
ISLE OF WIGHT 1.38 (0.63, 3.01)
KOALA 2.82 (1.10, 7.26)
LEICESTER 1990 3.12 (0.10, 102.33)
LEICESTER 1998 1.26 (0.92, 1.74)
LIFEWAYS 0.68 (0.19, 2.46)
PIAMA 0.71 (0.38, 1.33)
SEATON 1.46 (0.59, 3.61)
SWS 0.97 (0.43, 2.21)
WHISTLER 1.69 (0.28, 10.09)
1.40 (1.18, 1.67)
0.1 0.2 0.5 1 2 5 10
Study name Statistics for each study
Odds ratio (95% CI) Relative weight %
6.06
13.14
1.21
5.56
17.40
4.81
7.64
8.72
1.24
4.05
2.96
0.25
11.74
1.72
5.64
3.19
3.72
0.93
POOLED
Q = 29, p = 0.034, I² = 42%
A
B
FIG 3. Meta-analysis for associations of preterm birth and low birth weight with preschool wheezing and
school-age asthma. A, Preterm birth and preschool wheezing. B, Preterm birth and school-age asthma. C,
Low birth weight and preschool wheezing. D, Low birth weight and school-age asthma. Values from
random-effects models reflect ORs (95% CIs) of preschool wheezing and school-age asthma in preterm chil-
dren (<37 weeks) compared with those in children born at term (>_37 weeks) adjusted for birth weight (A and
B) and of preschool wheezing and school-age asthma in low-birth-weight children (<2500 g) compared with
children born with a normal birth weight (>_2500 g) adjusted for gestational age at birth (C and D). Arrows
represent 95% CIs that exceed the outer limits (0.1-10). Models are adjusted for confounders (see the
Methods section).
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with a high weight at birth had an increased risk of asthma be-
tween 6months and 31 years of age. Theywere not able to explore
the role of confounders or the effect of gestational age at birth. No
association of gestational age with childhood asthma waspresented. Because these reports were based on published results,
they might be biased and unable to take account of differences in
adjustment. A recent analysis by Rzehak et al33 of 8 European
cohort studies with 12,050 participants observed an increased
incidence of asthma until the age of 6 years in children with a
Study name Statistics for each study
Odds ratio (95% CI)
ABIS 1.44 (1.03, 2.02)
ALSPAC 1.18 (0.98, 1.44)
BILD 1.34 (0.24, 7.57)
CONER 0.91 (0.26, 3.18)
DNBC 1.16 (1.03, 1.30)
EDEN 1.22 (0.70, 2.12)
GASPII 0.65 (0.30, 1.42)
GECKO 0.79 (0.36, 1.71)
GENERATION R 0.82 (0.59, 1.15)
GENERATION XXI 1.04 (0.83, 1.31)
HUMIS 1.99 (1.04, 3.80)
INMA GIPUZKOA 0.98 (0.35, 2.78)
INMA MENORCA 0.65 (0.28, 1.52)
INMA SABADELL 1.92 (0.62, 5.97)
INMA VALENCIA 1.70 (0.65, 4.45)
ISLE OF WIGHT 2.30 (1.06, 5.01)
KOALA 0.65 (0.30, 1.42)
LEICESTER 1990 2.50 (0.58, 10.76)
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FIG 3. (Continued)
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SONNENSCHEIN-VAN DER VOORT ET AL 1325high gain of body mass index (BMI) in the first 2 years. In line
with this study, we observed increased risk for wheezing and
asthma in children with an increased infant weight gain.
Combining childhood asthma outcomes from different age
periods is not easy. Asthma is a difficult clinical diagnosis and
cannot easily be diagnosed in children younger than 5 years.
Many studies used asthma-related outcomes, such as wheezing
and shortness of breath, as main outcomes in children. Wheezing
seems to be the strongest risk factor for childhood asthma.34 Still,
wheezing in different age periods might reflect different physio-
logic mechanisms.35 For example, wheezing in infants might
reflect viral airway infections instead of asthma.35 Therefore we
used both wheezing in preschool children and asthma diagnosis
in school-age children as outcomes. We observed that both ayounger gestational age at birth and higher infant weight gain
were associated with an increased risk of preschool wheezing
and school-age asthma. For both gestational age at birth and in-
fant weight gain, we observed dose-response associations with
childhood asthma outcomes. The associations were not restricted
to the extremes of the distribution but present across the full range
of gestational age at birth and infant weight gain. To the best of
our knowledge, this study is the first showing these associations
within the normal ranges. Our results also suggest that the previ-
ously observed associations of low birth weight with childhood
asthma were largely explained by gestational age at birth. We
observed the highest risk of childhood asthma outcomes among
children born before a gestational age of 32 weeks with high
weight gain in infancy.
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Mechanisms underlying the associations of factors in early life
with asthma outcomes in later childhood might include smaller
airways and lungs.36 The highest rates of airway and alveolar
development occur in early life, and growth and development of
the airways and alveoli might continue until the age of 21
years.37,38 Extremely premature-born children with respiratory
distress syndrome or chronic lung disease commonly have
impaired lung function in later life.39,40 Follow-up studies in
preterm children showed persistently lower lung volumes and
reduced airway caliber in later life.40-44 However, these extremes
do not explain our associations within the less extreme range of
gestational age. Children born preterm also have higher
chemokine and cytokine levels in nasopharyngeal aspirates at 1
year compared with term-born children, which suggests that
preterm-born children are more responsive to proinflammatory
stimuli.45 The observed associations of high infant weight gain
with childhood asthma outcomes are in line with previous studies
reporting associations of BMI or adiposity with asthma.33,46,47
These associations might be explained by immunologically active
factors from adipose tissue, such as leptin.48 In mice leptin has
been shown to enhance airway hyperresponsiveness, suggesting
an immunomodulatory role.49 Results in human subjects are
inconsistent.50-52 High infant weight gain might also have a direct
mechanical effect on lung function.53 Further studies are needed
to identify the developmental adaptations of the lungs and
immune system that might explain the associations of preterm
birth and infant weight gain with childhood asthma.Strengths and limitations
We performed a large meta-analysis of individual participants’
data from many birth cohorts throughout Europe. We did not rely
on published data, which limits any potential publication bias. The
large number of participants enabled us to assess small effects and
to adjust for various potential confounders. We presented results
from random-effectsmodels, which allowheterogeneity in the true
effect estimates between different populations and take between-
study variation into account. Another strength is that information
on exposures in early life was collected from records and did not
depend on long-term participant recall. Misclassification of
gestational age is always possible because of the large number
of pregnant women who did not know their exact gestational
duration.54,55 Misclassification of gestational age might have
increased the number of children born postterm with a small
size for gestational age and children born preterm with a large
size for gestational age. Most cohorts used standardized and vali-
dated questionnaires to assess wheezing and asthma. This method
is widely accepted in epidemiologic studies and reliably reflects
the incidence of wheezing and asthma in children.22,56 Multiple
imputation has been suggested to be the preferable method to
deal with missing values.57 However, we did not have additional
data on patterns of missing values and were therefore unable to
perform multiple imputations within cohorts. We used missing
values in covariates as an additional group to prevent exclusion
of noncomplete cases. No differences in results were observed be-
tween themissing as extra category and complete case analyses. In
the current study we were not able to assess the effects of early
growth characteristics on other objective asthma-related out-
comes, such as lung function or bronchial hyperresponsiveness.
Although we did take major potential confounders into account,residual confounding might still be an issue. For example,
although cohorts comprised predominantly white children, we
were unable to adjust for ethnicity. Also, we were unable to adjust
for maternal BMI or chorioamnionitis, which might influence
growth and inflammatory factors associated with childhood
asthma.58,59Wewere not able to take BMI at the time of obtaining
information on childhood asthma outcomes into account. Espe-
cially the associations of infantweight gainwith childhood asthma
outcomes might be explained by later adiposity. Childhood
adiposity might be an intermediate in this association.Conclusions
Younger gestational age at birth and higher weight gain in
infancy were associated with childhood asthma outcomes. The
association of lower birth weight with childhood asthma out-
comes was largely explained by gestational age at birth. Further
studies are needed to evaluate the effects of early-life character-
istics on specific asthma-related outcomes, such as lung function,
airway size, and airway inflammation.
Per cohort
ABIS
Data used for this research was provided by the Cohort Study, which is
supported in part by JDRF-Wallenberg foundations (K 98-99D-12813-01A),
the Swedish Medical Research Council (MFR; Vetenskapsradet; K99-72X-
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Clinical implications: Children born at a younger gestational
age at birth or higher infant weight gain have increased risks
of childhood asthma.REFERENCES
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